Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
User-friendly multifactor mobile authentication
Lithium secondary battery
Cooling device for the air conditioning of an examination area of a medical examination apparatus and medical examination apparatus comprising a cooling device
Ion generating device
Magnetic control plane
Information processing apparatus, information processing method and program
Protecting caller function from undesired access by callee function
  Randomly Featured Patents
Rapid and sensitive method to measure endonuclease activity
Method and device for measuring propeller surface
Latent image thick refractive index recordings
Compensation of back pattern effect in a memory device
Process for producing acrolein
Probe for data storage apparatus
Loud speaker with minimized magnetic leakage
Rolling mills and operation thereof
Transistor and method
Zipper arrangement with foldable pull